METTL3-mediated m6A modification promotes tumor progression in upper tract urothelial carcinoma

被引：0
|
作者：
Lin, Li-Jie
Peng, Pei-Hua
Hsu, Kai-Wen
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1737
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1737
引用
收藏
页数：2
相关论文
共 50 条
  • [1] METTL3-mediated m6A modification of CDCA7 mRNA promotes COAD progression
    Hua, Mei
    Zhai, Xiaolu
    Chen, Ying
    Yin, Dian
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 260
  • [2] METTL3-Mediated m6A Modification of FMRP Drives Hepatocellular Carcinoma Progression and Indicates Poor Prognosis
    Fu, Siyuan
    Sun, Dapeng
    Wang, Zongyan
    Zhu, Peng
    Ding, Wenbin
    Huang, Jian
    Guo, Xinggang
    Yang, Yun
    Gu, Fangming
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2024, 39 (10) : 745 - 754
  • [3] METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance
    Wang, Qiang
    Chen, Chen
    Ding, Qingqing
    Zhao, Yan
    Wang, Zhangding
    Chen, Junjie
    Jiang, Zerun
    Zhang, Yan
    Xu, Guifang
    Zhang, Jingjing
    Zhou, Jianwei
    Sun, Beicheng
    Zou, Xiaoping
    Wang, Shouyu
    GUT, 2020, 69 (07) : 1193 - 1205
  • [4] METTL3-mediated m6A modification of ZNF384 promotes hepatocellular carcinoma progression by transcriptionally activating ACSM1
    Zhang, Limei
    Wang, Jinfu
    Gui, Fenfang
    Peng, Fanzhou
    Deng, Weiping
    Zhu, Qian
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
  • [5] HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification
    Yang, Zhi
    Jiang, Xiaodi
    Li, Deming
    Jiang, Xiaofeng
    AGING-US, 2020, 12 (24): : 24967 - 24982
  • [6] METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway
    Han, Hui
    Yang, Chunlong
    Zhang, Shuishen
    Cheng, Maosheng
    Guo, Siyao
    Zhu, Yan
    Ma, Jieyi
    Liang, Yu
    Wang, Lu
    Zheng, Siyi
    Wang, Zhaoyu
    Chen, Demeng
    Jiang, Yi-Zhou
    Lin, Shuibin
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2021, 26 : 333 - 346
  • [7] METTL3-mediated m6A modification controls splicing factor abundance and contributes to CLL progression
    Wu, Yiming
    Jin, Meiling
    Fernandez, Mike
    Hart, Kevyn
    Liao, Aijun
    Fernandes, Stacey M.
    McDonald, Tinisha
    Chen, Zhenhua
    Roth, Daniel
    Ghoda, Lucy
    Marcucci, Guido
    Kalkum, Markus
    Pillai, Raju K.
    Danilov, Alexey V.
    Chen, Jianjun
    Brown, Jennifer R.
    Rosen, Steven T.
    Siddiqi, Tanya
    Wang, Lili
    CANCER RESEARCH, 2023, 83 (07)
  • [8] METTL3-Mediated m6A Modification Links Liver Homeostasis and Pathology
    Ma, Wenbo
    Wu, Tong
    AMERICAN JOURNAL OF PATHOLOGY, 2022, 192 (01): : 18 - 20
  • [9] DCLRE1B promotes tumor progression and predicts immunotherapy response through METTL3-mediated m6A modification in pancreatic cancer
    Lincheng Li
    Fei Wang
    Zhaoda Deng
    Gong Zhang
    Lin Zhu
    Zhiming Zhao
    Rong Liu
    BMC Cancer, 23
  • [10] DCLRE1B promotes tumor progression and predicts immunotherapy response through METTL3-mediated m6A modification in pancreatic cancer
    Li, Lincheng
    Wang, Fei
    Deng, Zhaoda
    Zhang, Gong
    Zhu, Lin
    Zhao, Zhiming
    Liu, Rong
    BMC CANCER, 2023, 23 (01)
12345